Skip to content

Development of Guided Respiration Mindfulness Therapy: Manualization and Evaluation of Therapist Training and Clinical Outcomes in the Treatment of Depression and Anxiety

Lloyd Lalande

Queensland University of Technology February 27, 2017 DOI: 10.5204/thesis.eprints.103980 (opens in new tab)

Read Full Text
Relevant Not relevant

Study at a glance

AI-extracted from the abstract
Characteristics Uncontrolled clinical trial Peer reviewed
Interventions mindfulness and relaxation
Topics Anxiety Depression Meditation
Citations 2
Key findings The authors report that a brief therapist training program was sufficient to teach basic skills in a breathwork intervention based on respiration self-regulation, mindfulness, and relaxation, and that an uncontrolled clinical trial of the intervention led to clinically significant change in depression and anxiety symptoms.

Abstract

This study proposed and evaluated a novel clinical breathwork intervention based on the use of self-regulation of respiration, mindfulness and relaxation as a treatment option for depression and anxiety. A therapist training program in the intervention was developed and evaluated, followed by an uncontrolled clinical trial assessing the interventions efficacy in the treatment of depression and anxiety. Results showed that a brief training program is sufficient to teach therapists basic skills in the intervention and that treatment can lead to clinically significant change in depression and anxiety symptoms.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Citations in the library

Cites 30

and 25 more in the library

Related reading

Explore topics

Anxiety Depression Meditation Breathwork